nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—muscle cancer	0.375	0.508	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—muscle cancer	0.124	0.167	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—muscle cancer	0.118	0.16	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—muscle cancer	0.0719	0.0974	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—muscle cancer	0.0501	0.0679	CbGbCtD
Dinoprost Tromethamine—GALR3—head—muscle cancer	0.00621	0.0537	CbGeAlD
Dinoprost Tromethamine—HPGDS—embryo—muscle cancer	0.00483	0.0418	CbGeAlD
Dinoprost Tromethamine—PTGER1—renal system—muscle cancer	0.00482	0.0417	CbGeAlD
Dinoprost Tromethamine—PTGER3—smooth muscle tissue—muscle cancer	0.00439	0.038	CbGeAlD
Dinoprost Tromethamine—PTGER3—renal system—muscle cancer	0.00423	0.0366	CbGeAlD
Dinoprost Tromethamine—TBXA2R—Small Ligand GPCRs—CNR1—muscle cancer	0.00416	0.0819	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—vagina—muscle cancer	0.00398	0.0344	CbGeAlD
Dinoprost Tromethamine—PTGER3—Small Ligand GPCRs—CNR1—muscle cancer	0.00375	0.0739	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—renal system—muscle cancer	0.00365	0.0316	CbGeAlD
Dinoprost Tromethamine—TBXA2R—testis—muscle cancer	0.00355	0.0307	CbGeAlD
Dinoprost Tromethamine—PTGFR—smooth muscle tissue—muscle cancer	0.00351	0.0304	CbGeAlD
Dinoprost Tromethamine—Ileus paralytic—Vincristine—muscle cancer	0.00343	0.0368	CcSEcCtD
Dinoprost Tromethamine—PTGER1—head—muscle cancer	0.00322	0.0279	CbGeAlD
Dinoprost Tromethamine—PTGIR—smooth muscle tissue—muscle cancer	0.00309	0.0268	CbGeAlD
Dinoprost Tromethamine—PTGIR—renal system—muscle cancer	0.00298	0.0258	CbGeAlD
Dinoprost Tromethamine—SLC22A11—renal system—muscle cancer	0.0029	0.0251	CbGeAlD
Dinoprost Tromethamine—HPGDS—tendon—muscle cancer	0.00285	0.0247	CbGeAlD
Dinoprost Tromethamine—SLC22A7—renal system—muscle cancer	0.00283	0.0245	CbGeAlD
Dinoprost Tromethamine—PTGER3—head—muscle cancer	0.00283	0.0245	CbGeAlD
Dinoprost Tromethamine—PTGFR—Small Ligand GPCRs—CNR1—muscle cancer	0.00281	0.0553	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—bone marrow—muscle cancer	0.00276	0.0239	CbGeAlD
Dinoprost Tromethamine—PTGIR—Small Ligand GPCRs—CNR1—muscle cancer	0.00275	0.0541	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Small Ligand GPCRs—CNR1—muscle cancer	0.00275	0.0541	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—testis—muscle cancer	0.00273	0.0236	CbGeAlD
Dinoprost Tromethamine—HPGDS—vagina—muscle cancer	0.00265	0.0229	CbGeAlD
Dinoprost Tromethamine—PTGFR—tendon—muscle cancer	0.00264	0.0228	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—renal system—muscle cancer	0.00263	0.0227	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—renal system—muscle cancer	0.0026	0.0225	CbGeAlD
Dinoprost Tromethamine—HPGDS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—muscle cancer	0.00254	0.0499	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—renal system—muscle cancer	0.00252	0.0218	CbGeAlD
Dinoprost Tromethamine—HPGDS—head—muscle cancer	0.00244	0.0211	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—muscle cancer	0.00241	1	CrCbGaD
Dinoprost Tromethamine—HPGDS—testis—muscle cancer	0.00236	0.0204	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—cardiac atrium—muscle cancer	0.00235	0.0204	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—cardiac atrium—muscle cancer	0.00233	0.0202	CbGeAlD
Dinoprost Tromethamine—PTGFR—head—muscle cancer	0.00226	0.0196	CbGeAlD
Dinoprost Tromethamine—PTGFR—testis—muscle cancer	0.00218	0.0189	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—tendon—muscle cancer	0.00205	0.0178	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—tendon—muscle cancer	0.00203	0.0176	CbGeAlD
Dinoprost Tromethamine—PTGIR—head—muscle cancer	0.00199	0.0172	CbGeAlD
Dinoprost Tromethamine—PTGIR—testis—muscle cancer	0.00192	0.0167	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—vagina—muscle cancer	0.0019	0.0165	CbGeAlD
Dinoprost Tromethamine—Extravasation—Dactinomycin—muscle cancer	0.0019	0.0204	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—vagina—muscle cancer	0.00189	0.0163	CbGeAlD
Dinoprost Tromethamine—SLC22A7—testis—muscle cancer	0.00183	0.0158	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—head—muscle cancer	0.00176	0.0152	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—head—muscle cancer	0.00174	0.0151	CbGeAlD
Dinoprost Tromethamine—Extravasation—Vincristine—muscle cancer	0.0017	0.0182	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—testis—muscle cancer	0.0017	0.0147	CbGeAlD
Dinoprost Tromethamine—Cyanosis—Etoposide—muscle cancer	0.0017	0.0182	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—testis—muscle cancer	0.00168	0.0146	CbGeAlD
Dinoprost Tromethamine—SLC22A8—renal system—muscle cancer	0.00164	0.0142	CbGeAlD
Dinoprost Tromethamine—Respiratory failure—Vincristine—muscle cancer	0.00151	0.0162	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Dactinomycin—muscle cancer	0.00144	0.0155	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Dactinomycin—muscle cancer	0.0014	0.015	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Etoposide—muscle cancer	0.00138	0.0148	CcSEcCtD
Dinoprost Tromethamine—Venous thrombosis—Doxorubicin—muscle cancer	0.00115	0.0124	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.00113	0.0223	CbGpPWpGaD
Dinoprost Tromethamine—Hypoxia—Methotrexate—muscle cancer	0.00113	0.0122	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—head—muscle cancer	0.0011	0.00948	CbGeAlD
Dinoprost Tromethamine—Sepsis—Etoposide—muscle cancer	0.00104	0.0112	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Methotrexate—muscle cancer	0.00104	0.0111	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Vincristine—muscle cancer	0.00102	0.011	CcSEcCtD
Dinoprost Tromethamine—Cyanosis—Methotrexate—muscle cancer	0.00102	0.0109	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Etoposide—muscle cancer	0.00101	0.0109	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.001	0.0198	CbGpPWpGaD
Dinoprost Tromethamine—Dehydration—Vincristine—muscle cancer	0.001	0.0107	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000979	0.0193	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac failure congestive—Etoposide—muscle cancer	0.000961	0.0103	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000916	0.018	CbGpPWpGaD
Dinoprost Tromethamine—Hyperventilation—Doxorubicin—muscle cancer	0.000905	0.00971	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Doxorubicin—muscle cancer	0.000896	0.00962	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Methotrexate—muscle cancer	0.000874	0.00938	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Vincristine—muscle cancer	0.000869	0.00933	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.000848	0.0167	CbGpPWpGaD
Dinoprost Tromethamine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.000841	0.00903	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.00083	0.0163	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	0.00083	0.0163	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac arrest—Etoposide—muscle cancer	0.000829	0.0089	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Methotrexate—muscle cancer	0.000824	0.00885	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCRs, Other—CNR1—muscle cancer	0.000802	0.0158	CbGpPWpGaD
Dinoprost Tromethamine—Sweating—Vincristine—muscle cancer	0.000795	0.00853	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000772	0.0152	CbGpPWpGaD
Dinoprost Tromethamine—Petechiae—Doxorubicin—muscle cancer	0.000757	0.00812	CcSEcCtD
Dinoprost Tromethamine—Chills—Dactinomycin—muscle cancer	0.000747	0.00802	CcSEcCtD
Dinoprost Tromethamine—Bronchospasm—Etoposide—muscle cancer	0.000741	0.00795	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000734	0.0144	CbGpPWpGaD
Dinoprost Tromethamine—Respiratory failure—Methotrexate—muscle cancer	0.000732	0.00786	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Methotrexate—muscle cancer	0.000719	0.00772	CcSEcCtD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—CNR1—muscle cancer	0.000718	0.0141	CbGpPWpGaD
Dinoprost Tromethamine—Extravasation—Doxorubicin—muscle cancer	0.000714	0.00766	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Vincristine—muscle cancer	0.000675	0.00725	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dactinomycin—muscle cancer	0.000673	0.00722	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000666	0.0131	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Dactinomycin—muscle cancer	0.000654	0.00702	CcSEcCtD
Dinoprost Tromethamine—Back pain—Vincristine—muscle cancer	0.000627	0.00673	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Methotrexate—muscle cancer	0.000624	0.0067	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—muscle cancer	0.000623	0.00668	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—muscle cancer	0.000623	0.00668	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dactinomycin—muscle cancer	0.00061	0.00655	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methotrexate—muscle cancer	0.000603	0.00647	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Methotrexate—muscle cancer	0.0006	0.00644	CcSEcCtD
Dinoprost Tromethamine—Agitation—Vincristine—muscle cancer	0.000595	0.00639	CcSEcCtD
Dinoprost Tromethamine—Infection—Dactinomycin—muscle cancer	0.000588	0.00631	CcSEcCtD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000571	0.0112	CbGpPWpGaD
Dinoprost Tromethamine—Convulsion—Vincristine—muscle cancer	0.000561	0.00603	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Vincristine—muscle cancer	0.000559	0.006	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Etoposide—muscle cancer	0.000547	0.00587	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—muscle cancer	0.000546	0.00586	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Etoposide—muscle cancer	0.000545	0.00585	CcSEcCtD
Dinoprost Tromethamine—Chills—Etoposide—muscle cancer	0.000541	0.00581	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—muscle cancer	0.00054	0.0058	CcSEcCtD
Dinoprost Tromethamine—Infection—Vincristine—muscle cancer	0.000525	0.00564	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—muscle cancer	0.000525	0.00563	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—muscle cancer	0.000522	0.00561	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—muscle cancer	0.00052	0.00558	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000517	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—PTCH1—muscle cancer	0.000515	0.0101	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Vincristine—muscle cancer	0.000511	0.00549	CcSEcCtD
Dinoprost Tromethamine—Back pain—Etoposide—muscle cancer	0.000508	0.00545	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—ANGPT2—muscle cancer	0.000507	0.00997	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Dactinomycin—muscle cancer	0.000506	0.00543	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Etoposide—muscle cancer	0.000505	0.00542	CcSEcCtD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—CNR1—muscle cancer	0.000502	0.00988	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000498	0.00535	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Vincristine—muscle cancer	0.000494	0.0053	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dactinomycin—muscle cancer	0.000488	0.00524	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Etoposide—muscle cancer	0.000487	0.00523	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000484	0.0052	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000478	0.00941	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Vincristine—muscle cancer	0.000475	0.0051	CcSEcCtD
Dinoprost Tromethamine—Malaise—Etoposide—muscle cancer	0.000473	0.00508	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dactinomycin—muscle cancer	0.000468	0.00502	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dactinomycin—muscle cancer	0.000468	0.00502	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000466	0.00917	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Etoposide—muscle cancer	0.000461	0.00495	CcSEcCtD
Dinoprost Tromethamine—Cough—Etoposide—muscle cancer	0.000458	0.00492	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Etoposide—muscle cancer	0.000455	0.00488	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Etoposide—muscle cancer	0.000453	0.00486	CcSEcCtD
Dinoprost Tromethamine—Pain—Vincristine—muscle cancer	0.000452	0.00485	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—muscle cancer	0.000452	0.00485	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Etoposide—muscle cancer	0.000447	0.0048	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000443	0.00871	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Etoposide—muscle cancer	0.000441	0.00474	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Dactinomycin—muscle cancer	0.000436	0.00468	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—CNR1—muscle cancer	0.000435	0.00856	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Vincristine—muscle cancer	0.000432	0.00464	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—muscle cancer	0.00043	0.00461	CcSEcCtD
Dinoprost Tromethamine—Infection—Etoposide—muscle cancer	0.000426	0.00457	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dactinomycin—muscle cancer	0.000425	0.00456	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—muscle cancer	0.000422	0.00453	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—muscle cancer	0.00042	0.00451	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Etoposide—muscle cancer	0.000418	0.00449	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Vincristine—muscle cancer	0.000418	0.00449	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Vincristine—muscle cancer	0.000418	0.00449	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Etoposide—muscle cancer	0.000414	0.00445	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000412	0.00812	CbGpPWpGaD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—muscle cancer	0.000411	0.00442	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dactinomycin—muscle cancer	0.000405	0.00435	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—muscle cancer	0.000402	0.00432	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Etoposide—muscle cancer	0.0004	0.0043	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—PTCH1—muscle cancer	0.000399	0.00786	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000399	0.00786	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KIDINS220—muscle cancer	0.000397	0.00781	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Vincristine—muscle cancer	0.00039	0.00418	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—muscle cancer	0.000386	0.00414	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Etoposide—muscle cancer	0.000385	0.00413	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—muscle cancer	0.000384	0.00412	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Etoposide—muscle cancer	0.000382	0.0041	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Etoposide—muscle cancer	0.000381	0.00409	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—muscle cancer	0.000379	0.00407	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Vincristine—muscle cancer	0.000379	0.00407	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dactinomycin—muscle cancer	0.000376	0.00404	CcSEcCtD
Dinoprost Tromethamine—Rash—Dactinomycin—muscle cancer	0.000373	0.00401	CcSEcCtD
Dinoprost Tromethamine—Pain—Etoposide—muscle cancer	0.000366	0.00393	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—muscle cancer	0.000365	0.00392	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Vincristine—muscle cancer	0.000362	0.00388	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—PTCH1—muscle cancer	0.00036	0.00709	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Etoposide—muscle cancer	0.000353	0.00379	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dactinomycin—muscle cancer	0.000352	0.00377	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Etoposide—muscle cancer	0.00035	0.00376	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vincristine—muscle cancer	0.00035	0.00375	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000348	0.00686	CbGpPWpGaD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—muscle cancer	0.000348	0.00374	CcSEcCtD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000341	0.00671	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CNR1—muscle cancer	0.000341	0.00671	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—muscle cancer	0.000339	0.00667	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Etoposide—muscle cancer	0.000339	0.00363	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—muscle cancer	0.000339	0.00363	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—muscle cancer	0.000339	0.00363	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CNR1—muscle cancer	0.000337	0.00663	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Vincristine—muscle cancer	0.000336	0.00361	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Hemostasis—ANGPT2—muscle cancer	0.000335	0.00659	CbGpPWpGaD
Dinoprost Tromethamine—Sweating—Doxorubicin—muscle cancer	0.000334	0.00358	CcSEcCtD
Dinoprost Tromethamine—Rash—Vincristine—muscle cancer	0.000333	0.00358	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Vincristine—muscle cancer	0.000333	0.00358	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—muscle cancer	0.000332	0.00357	CcSEcCtD
Dinoprost Tromethamine—Headache—Vincristine—muscle cancer	0.000331	0.00356	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—muscle cancer	0.000329	0.00353	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—muscle cancer	0.000328	0.00352	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—muscle cancer	0.000326	0.0035	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000325	0.0064	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—FH—muscle cancer	0.000325	0.0064	CbGpPWpGaD
Dinoprost Tromethamine—Chills—Methotrexate—muscle cancer	0.000324	0.00348	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—muscle cancer	0.000318	0.00342	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—muscle cancer	0.000316	0.00339	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vincristine—muscle cancer	0.000314	0.00337	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000314	0.00617	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KIDINS220—muscle cancer	0.000307	0.00605	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Etoposide—muscle cancer	0.000307	0.0033	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—muscle cancer	0.000304	0.00326	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CNR1—muscle cancer	0.000304	0.00598	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Etoposide—muscle cancer	0.000303	0.00325	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000298	0.00588	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Etoposide—muscle cancer	0.000293	0.00315	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000292	0.00575	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000292	0.00575	CbGpPWpGaD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—muscle cancer	0.000292	0.00313	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—muscle cancer	0.000284	0.00305	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—muscle cancer	0.000283	0.00304	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—muscle cancer	0.000283	0.00304	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—muscle cancer	0.000282	0.00303	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—muscle cancer	0.000281	0.00301	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KIDINS220—muscle cancer	0.000277	0.00546	CbGpPWpGaD
Dinoprost Tromethamine—Cough—Methotrexate—muscle cancer	0.000274	0.00294	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—muscle cancer	0.000272	0.00292	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—muscle cancer	0.000272	0.00292	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—muscle cancer	0.00027	0.0029	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—muscle cancer	0.00027	0.0029	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—PTCH1—muscle cancer	0.000269	0.0053	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Etoposide—muscle cancer	0.000268	0.00288	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—muscle cancer	0.000268	0.00287	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—muscle cancer	0.000264	0.00284	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PTCH1—muscle cancer	0.000264	0.0052	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—PTCH1—muscle cancer	0.000264	0.00519	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—PTCH1—muscle cancer	0.000264	0.00519	CbGpPWpGaD
Dinoprost Tromethamine—Back pain—Doxorubicin—muscle cancer	0.000263	0.00283	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—muscle cancer	0.000262	0.00281	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—muscle cancer	0.000255	0.00274	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—muscle cancer	0.000254	0.00273	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000253	0.00271	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—muscle cancer	0.00025	0.00269	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—muscle cancer	0.000248	0.00266	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000247	0.00486	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IGF2—muscle cancer	0.000246	0.00485	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—CNR1—muscle cancer	0.000246	0.00483	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Doxorubicin—muscle cancer	0.000245	0.00264	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—muscle cancer	0.000244	0.00262	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—muscle cancer	0.00024	0.00257	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—muscle cancer	0.000239	0.00257	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—muscle cancer	0.000238	0.00255	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—muscle cancer	0.000236	0.00253	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—muscle cancer	0.000235	0.00252	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—muscle cancer	0.000232	0.00249	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—muscle cancer	0.00023	0.00247	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—muscle cancer	0.000229	0.00246	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—muscle cancer	0.000229	0.00246	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—muscle cancer	0.000228	0.00245	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CNR1—muscle cancer	0.000227	0.00447	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CNR1—muscle cancer	0.000223	0.00439	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CNR1—muscle cancer	0.000222	0.00438	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CNR1—muscle cancer	0.000222	0.00438	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Doxorubicin—muscle cancer	0.000221	0.00237	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—muscle cancer	0.000219	0.00236	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—muscle cancer	0.000219	0.00235	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—muscle cancer	0.000217	0.00233	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000215	0.00231	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—muscle cancer	0.000211	0.00227	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00021	0.00225	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—muscle cancer	0.000208	0.00223	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIDINS220—muscle cancer	0.000207	0.00408	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PTCH1—muscle cancer	0.000205	0.00403	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIDINS220—muscle cancer	0.000203	0.004	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIDINS220—muscle cancer	0.000203	0.004	CbGpPWpGaD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—muscle cancer	0.000203	0.00218	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—muscle cancer	0.000203	0.00218	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.0002	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—muscle cancer	0.000199	0.00214	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—muscle cancer	0.000198	0.00213	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—muscle cancer	0.000198	0.00212	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—CNR1—muscle cancer	0.00019	0.00375	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Doxorubicin—muscle cancer	0.00019	0.00204	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—muscle cancer	0.000189	0.00203	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000187	0.00367	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTCH1—muscle cancer	0.000185	0.00364	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Methotrexate—muscle cancer	0.000184	0.00198	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—MED12—muscle cancer	0.000184	0.00362	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—muscle cancer	0.000183	0.00197	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000182	0.00195	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—muscle cancer	0.000182	0.00195	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—muscle cancer	0.000176	0.00189	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—muscle cancer	0.000176	0.00189	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—muscle cancer	0.000176	0.00188	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CNR1—muscle cancer	0.000173	0.0034	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—CNR1—muscle cancer	0.000172	0.00338	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Methotrexate—muscle cancer	0.00017	0.00182	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—ENO2—muscle cancer	0.000167	0.0033	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—muscle cancer	0.000164	0.00176	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—muscle cancer	0.000163	0.00175	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Hemostasis—IGF2—muscle cancer	0.000163	0.0032	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Methotrexate—muscle cancer	0.000162	0.00174	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—muscle cancer	0.000162	0.00173	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—muscle cancer	0.000161	0.00173	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—muscle cancer	0.000159	0.00171	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—muscle cancer	0.000157	0.00169	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTCH1—muscle cancer	0.000156	0.00307	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CNR1—muscle cancer	0.000156	0.00307	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Methotrexate—muscle cancer	0.000152	0.00164	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—muscle cancer	0.000152	0.00163	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—muscle cancer	0.000147	0.00158	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—muscle cancer	0.000141	0.00152	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—muscle cancer	0.00014	0.0015	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—muscle cancer	0.00014	0.0015	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—muscle cancer	0.000139	0.00149	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTCH1—muscle cancer	0.000138	0.00272	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTCH1—muscle cancer	0.000135	0.00266	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTCH1—muscle cancer	0.000135	0.00266	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FOXO4—muscle cancer	0.000134	0.00264	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Doxorubicin—muscle cancer	0.000132	0.00142	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CNR1—muscle cancer	0.000132	0.00259	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000131	0.00258	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CNR1—muscle cancer	0.000128	0.00253	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CNR1—muscle cancer	0.000126	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CNR1—muscle cancer	0.000126	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTCH1—muscle cancer	0.000121	0.00238	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CNR1—muscle cancer	0.000117	0.0023	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CNR1—muscle cancer	0.000114	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CNR1—muscle cancer	0.000114	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTCH1—muscle cancer	0.000109	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF2—muscle cancer	0.000108	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FOXO4—muscle cancer	0.000104	0.00205	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—muscle cancer	0.000103	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CNR1—muscle cancer	0.000102	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FOXO1—muscle cancer	9.91e-05	0.00195	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FOXO4—muscle cancer	9.39e-05	0.00185	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CNR1—muscle cancer	9.22e-05	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—FH—muscle cancer	8.47e-05	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF2—muscle cancer	8.35e-05	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	8.17e-05	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTCH1—muscle cancer	8.16e-05	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTCH1—muscle cancer	7.99e-05	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTCH1—muscle cancer	7.99e-05	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—muscle cancer	7.81e-05	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FOXO1—muscle cancer	7.69e-05	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KIT—muscle cancer	7.55e-05	0.00149	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF2—muscle cancer	7.53e-05	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FOXO4—muscle cancer	7.02e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FOXO1—muscle cancer	6.93e-05	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CNR1—muscle cancer	6.89e-05	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FOXO4—muscle cancer	6.87e-05	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FOXO4—muscle cancer	6.87e-05	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—muscle cancer	6.82e-05	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CNR1—muscle cancer	6.74e-05	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CNR1—muscle cancer	6.74e-05	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—MDM2—muscle cancer	6.26e-05	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MDM2—muscle cancer	5.95e-05	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KIT—muscle cancer	5.86e-05	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—muscle cancer	5.83e-05	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF2—muscle cancer	5.63e-05	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF2—muscle cancer	5.51e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF2—muscle cancer	5.51e-05	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KIT—muscle cancer	5.28e-05	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FOXO1—muscle cancer	5.18e-05	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—muscle cancer	5.15e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FOXO1—muscle cancer	5.07e-05	0.000999	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FOXO1—muscle cancer	5.07e-05	0.000999	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MED12—muscle cancer	4.78e-05	0.000942	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MDM2—muscle cancer	4.61e-05	0.000908	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—muscle cancer	4.52e-05	0.000889	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO2—muscle cancer	4.36e-05	0.000858	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MDM2—muscle cancer	4.16e-05	0.000819	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIT—muscle cancer	3.95e-05	0.000778	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIT—muscle cancer	3.87e-05	0.000761	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIT—muscle cancer	3.87e-05	0.000761	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—muscle cancer	3.5e-05	0.000689	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—muscle cancer	3.41e-05	0.000672	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—muscle cancer	3.16e-05	0.000622	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MDM2—muscle cancer	3.11e-05	0.000612	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MDM2—muscle cancer	3.05e-05	0.000599	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MDM2—muscle cancer	3.05e-05	0.000599	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—muscle cancer	2.65e-05	0.000521	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—muscle cancer	2.39e-05	0.00047	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—muscle cancer	2.36e-05	0.000465	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—muscle cancer	2.31e-05	0.000455	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—muscle cancer	2.31e-05	0.000455	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—muscle cancer	1.79e-05	0.000351	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—muscle cancer	1.75e-05	0.000344	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—muscle cancer	1.75e-05	0.000344	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—muscle cancer	1.52e-05	0.000299	CbGpPWpGaD
